{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:21:25Z","timestamp":1790396485088,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":3009,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/mi.2013.16","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T08:24:35Z","timestamp":1365582275000},"page":"1168-1178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The immune complex CTA1-DD\/IgG adjuvant specifically targets connective tissue mast cells through Fc\u03b3RIIIA and augments anti-HPV immunity after nasal immunization"],"prefix":"10.1016","volume":"6","author":[{"given":"Y","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lidell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mi.2013.16_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2013.16_bib2","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","article-title":"Induction of secretory immunity and memory at mucosal surfaces","volume":"25","author":"Brandtzaeg","year":"2007","journal-title":"Vaccine"},{"key":"10.1038\/mi.2013.16_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1038\/mi.2013.16_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2007.11.003","article-title":"How do adjuvants work? Important considerations for new generation adjuvants","volume":"27","author":"McKee","year":"2007","journal-title":"Immunity"},{"key":"10.1038\/mi.2013.16_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"Lambrecht","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1038\/mi.2013.16_bib6","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/IAI.73.10.6892-6902.2005","article-title":"Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract","volume":"73","author":"van Ginkel","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1038\/mi.2013.16_bib7","first-page":"188","article-title":"From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development","volume":"133","author":"Svennerholm","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1038\/mi.2013.16_bib8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm1757","article-title":"Mast cell activators: a new class of highly effective vaccine adjuvants","volume":"14","author":"McLachlan","year":"2008","journal-title":"Nat. Med."},{"key":"10.1038\/mi.2013.16_bib9","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1016\/j.vaccine.2009.03.069","article-title":"The mast cell activator compound 48\/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen","volume":"27","author":"McGowen","year":"2009","journal-title":"Vaccine"},{"key":"10.1038\/mi.2013.16_bib10","doi-asserted-by":"crossref","first-page":"e16532","DOI":"10.1371\/journal.pone.0016532","article-title":"Mucosal targeting of a BoNT\/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT\/A neutralizing antibodies in rabbits","volume":"6","author":"Staats","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mi.2013.16_bib11","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.162.4.2432","article-title":"Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity","volume":"162","author":"Agren","year":"1999","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mi.2010.54","article-title":"Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins","volume":"3","author":"Lycke","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2013.16_bib13","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.1002881","article-title":"A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development","volume":"186","author":"Bemark","year":"2011","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib14","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.4049\/jimmunol.1101107","article-title":"Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant","volume":"187","author":"Mattsson","year":"2011","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib15","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.158.8.3936","article-title":"Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit","volume":"158","author":"Agren","year":"1997","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib16","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.4049\/jimmunol.1000589","article-title":"Mast cells contribute to the mucosal adjuvant effect of CTA1-DD after IgG-complex formation","volume":"185","author":"Fang","year":"2010","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2222.2007.02886.x","article-title":"The mast cell and allergic diseases: role in pathogenesis and implications for therapy","volume":"38","author":"Brown","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1038\/mi.2013.16_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.immuni.2008.02.008","article-title":"Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis","volume":"28","author":"Tsujimura","year":"2008","journal-title":"Immunity"},{"key":"10.1038\/mi.2013.16_bib19","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.189.10.1573","article-title":"Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG","volume":"189","author":"Ujike","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1038\/mi.2013.16_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4049\/jimmunol.81.4.355","article-title":"Passive cutaneous anaphylaxis in the mouse","volume":"81","author":"Ovary","year":"1958","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib21","first-page":"655","article-title":"Homologous passive cutaneous anaphylaxis (PCA) in mice and heterologous PCA induced in rats with mouse IgE","volume":"30","author":"Braga","year":"1976","journal-title":"Immunology"},{"key":"10.1038\/mi.2013.16_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2007.00510.x","article-title":"The mast cell IgG receptors and their roles in tissue inflammation","volume":"217","author":"Malbec","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1038\/mi.2013.16_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/intimm\/11.2.199","article-title":"Fc receptor beta subunit is required for full activation of mast cells through Fc receptor engagement","volume":"11","author":"Hiraoka","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1038\/mi.2013.16_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/mi.2009.136","article-title":"Advances in mast cell biology: new understanding of heterogeneity and function","volume":"3","author":"Moon","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2013.16_bib25","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.149.6.2155","article-title":"Induction of tumor necrosis factor-alpha production by mast cells via Fc gamma R. Role of the Fc gamma RIII gamma subunit","volume":"149","author":"Latour","year":"1992","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib26","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.178.7.4177","article-title":"FcepsilonRI aggregation promotes survival of connective tissue-like mast cells but not mucosal-like mast cells","volume":"178","author":"Ekoff","year":"2007","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jlb.61.3.233","article-title":"Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase","volume":"61","author":"Welle","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1038\/mi.2013.16_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.iy.07.040189.000423","article-title":"Heterogeneity of mast cells and phenotypic change between subpopulations","volume":"7","author":"Kitamura","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1038\/mi.2013.16_bib29","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1073\/pnas.84.24.9175","article-title":"Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor","volume":"84","author":"Young","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1038\/mi.2013.16_bib30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.bjp.0703672","article-title":"Chondroitin sulphate inhibits connective tissue mast cells","volume":"131","author":"Theoharides","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1038\/mi.2013.16_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00418-002-0425-z","article-title":"Mast cells and macrophages in normal C57\/BL\/6 mice","volume":"118","author":"Gersch","year":"2002","journal-title":"Histochem. Cell Biol."},{"key":"10.1038\/mi.2013.16_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0625.2009.00878.x","article-title":"Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands","volume":"18","author":"Mrabet-Dahbi","year":"2009","journal-title":"Exp. Dermatol."},{"key":"10.1038\/mi.2013.16_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.4.6.6912","article-title":"Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16\/18 cervical cancer vaccine","volume":"4","author":"Dessy","year":"2008","journal-title":"Hum. Vaccin."},{"key":"10.1038\/mi.2013.16_bib34","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/j.vaccine.2010.02.057","article-title":"Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types","volume":"28","author":"Zhang","year":"2010","journal-title":"Vaccine"},{"key":"10.1038\/mi.2013.16_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2013.16_bib36","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/eji.201040559","article-title":"Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity","volume":"40","author":"Galli","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1038\/mi.2013.16_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni1158","article-title":"Mast cells in the development of adaptive immune responses","volume":"6","author":"Galli","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1038\/mi.2013.16_bib38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri2327","article-title":"Immunomodulatory mast cells: negative, as well as positive, regulators of immunity","volume":"8","author":"Galli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2013.16_bib39","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4049\/jimmunol.177.3.1755","article-title":"Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan","volume":"177","author":"Jawdat","year":"2006","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib40","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.4049\/jimmunol.176.7.4102","article-title":"Mast cell-associated TNF promotes dendritic cell migration","volume":"176","author":"Suto","year":"2006","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib41","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2006-07-036889","article-title":"Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice","volume":"110","author":"Heib","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mi.2013.16_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.chom.2009.09.004","article-title":"Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues","volume":"6","author":"Shelburne","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1038\/mi.2013.16_bib43","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.4049\/jimmunol.0803894","article-title":"Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node","volume":"184","author":"Dawicki","year":"2010","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib44","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0021-9258(18)54061-8","article-title":"Intracellular degradation of Fc gamma RIII in mouse bone marrow culture-derived progenitor mast cells prevents its surface expression and associated function","volume":"268","author":"Lobell","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1038\/mi.2013.16_bib45","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF02142570","article-title":"The effect of compound 48\/80 and of electrical field stimulation on mast cells in the isolated mouse stomach","volume":"23","author":"Stanovnik","year":"1988","journal-title":"Agents Actions"},{"key":"10.1038\/mi.2013.16_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00232005","article-title":"Long term increase of mucosal mast cells in the rat induced by administration of compound 48\/80","volume":"198","author":"Enerback","year":"1979","journal-title":"Cell Tissue Res."},{"key":"10.1038\/mi.2013.16_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.173.1.531","article-title":"TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells","volume":"173","author":"Matsushima","year":"2004","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2013.16_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2013.16_bib49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2013.16_bib50","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.addr.2006.07.015","article-title":"Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway","volume":"58","author":"Bitonti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1038\/mi.2013.16_bib51","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Suppl 3","key":"10.1038\/mi.2013.16_bib52","first-page":"C1","article-title":"HPV and cervical cancer in the 2007 report","volume":"25","author":"WHO\/ICO Information Centre on HPV and Cervical Cancer","year":"2007","journal-title":"Vaccine"},{"key":"10.1038\/mi.2013.16_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2007.05.005","article-title":"Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants","volume":"76","author":"Revaz","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1038\/mi.2013.16_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virusres.2005.02.001","article-title":"A human papillomavirus type 16 vaccine by oral delivery of L1 protein","volume":"110","author":"Sasagawa","year":"2005","journal-title":"Virus Res."},{"key":"10.1038\/mi.2013.16_bib55","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1016\/j.vaccine.2005.02.019","article-title":"Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine","volume":"23","author":"Nardelli-Haefliger","year":"2005","journal-title":"Vaccine"},{"key":"10.1038\/mi.2013.16_bib56","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1128\/JVI.73.11.9609-9613.1999","article-title":"Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice","volume":"73","author":"Nardelli-Haefliger","year":"1999","journal-title":"J. Virol."},{"key":"10.1038\/mi.2013.16_bib57","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1016\/j.vaccine.2011.04.051","article-title":"Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses","volume":"29","author":"Hunter","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1038\/mi.2013.16_bib58","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/01.qai.0000167040.58181.d5","article-title":"Effect of the menstrual cycle on immunological parameters in the human female reproductive tract","volume":"38","author":"Wira","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1038\/mi.2013.16_bib59","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1128\/JVI.77.8.4558-4565.2003","article-title":"Progesterone increases susceptibility and decreases immune responses to genital herpes infection","volume":"77","author":"Kaushic","year":"2003","journal-title":"J. Virol."},{"key":"10.1038\/mi.2013.16_bib60","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/eji.201040994","article-title":"Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function","volume":"41","author":"Dudeck","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1038\/mi.2013.16_bib61","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1046\/j.1365-2222.2000.00906.x","article-title":"IgE receptor-mediated release of nerve growth factor by mast cells","volume":"30","author":"Xiang","year":"2000","journal-title":"Clin. Exp. Allergy"},{"key":"10.1038\/mi.2013.16_bib62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000094895","article-title":"Readministration of IgE is required for repeated passive cutaneous anaphylaxis in mice","volume":"141","author":"Xiang","year":"2006","journal-title":"Int. Arch. Allergy Immunol."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mi201316.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi201316","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922012703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922012703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi201316.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:24:13Z","timestamp":1761830653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922012703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1933021922012703"],"URL":"https:\/\/doi.org\/10.1038\/mi.2013.16","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immune complex CTA1-DD\/IgG adjuvant specifically targets connective tissue mast cells through Fc\u03b3RIIIA and augments anti-HPV immunity after nasal immunization","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mi.2013.16","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/mi.2013.81","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 Society for Mucosal Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}